Evidence map›Paper›PMID 37895177›Full record

ArticleInternational journal of molecular sciences2023

Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma.

Andrzej T Slominski, Tae-Kang Kim, Radomir M Slominski, Yuwei Song, Shariq Qayyum, Wojciech Placha, Zorica Janjetovic, Konrad Kleszczyński, Venkatram Atigadda, Yuhua Song and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Protective Effect of Melatonin Against Bisphenol A Toxicity.International journal of molecular sciences · 2025
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Andrzej T SlominskiDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0001-8963-3995
Tae-Kang KimDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0003-1394-4134
Radomir M SlominskiDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Yuwei SongDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Shariq QayyumDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0003-0777-1994
Wojciech PlachaDepartment of Medicinal Biochemistry, Collegium Medicum, Jagiellonian University, 31-008 Kraków, Poland.
Zorica JanjetovicDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Konrad KleszczyńskiDepartment of Dermatology, University of Münster, Von-Esmarch-Str. 58, 48161 Münster, Germany.ORCID 0000-0002-1311-263X
Venkatram AtigaddaDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Yuhua SongDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Chander RamanDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Cornelis J ElferinkDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 79567, USA.ORCID 0000-0002-1281-7400
Judith Varady HobrathSygnature Discovery, Discovery Building, Biocity, Nottingham NG1 1GF, UK.
Anton M JettenCell Biology Section, NIEHS, National Institutes of Health, Research Triangle Park, NC 27709, USA.
Russel J ReiterDepartment of Cell Systems and Anatomy, UT Health, Long School of Medicine, San Antonio, TX 78229, USA.ORCID 0000-0001-6763-4225
University of Alabama at Birmingham · USBrigham and Women's Hospital · USJagiellonian University · PLNational Institutes of Health · USThe University of Texas Health Science Center at San Antonio · USThe University of Texas Medical Branch at Galveston · USUniversity of Münster · DE

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Omer Jamy · 1985 to 2026
$165.9M
Nuclear receptors--Action, functions, &roles in diseaseZ01ES101586 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI JETTEN, ANTON M · 2003 to 2008
$3.2M
Mechanism of action and function of novel secosteroid 20(OH)D3 in the skinR01AR073004 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ANDRZEJ T SLOMINSKI · 2018 to 2026
$2.9M
Drugs repositioning to target TREM2 in Alzheimer diseaseR01AG081228 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Yuhua Song · 2023 to 2026
$2.3M
TREM2-endogenous ligand interactions in Alzheimer diseaseR01AG068395 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SONG, YUHUA · 2021 to 2025
$2.1M
Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of ActionR01ES033682 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Casey W Wright · 2022 to 2026
$1.8M
Significance of metabolic activation of lumisterol in the skinR01AR071189 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SLOMINSKI, ANDRZEJ T · 2017 to 2021
$1.6M
Canonical and non-canonical vitamin D activation pathways in systemic lupusR21AI149267 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RAMAN, CHANDER, SLOMINSKI, ANDRZEJ T · 2020 to 2021
$408k
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancerI01BX004293 · VA · BIRMINGHAM VA MEDICAL CENTER · PI SLOMINSKI, ANDRZEJ T · 2019 to 2025
–
BLRD VA I01 BX004293Intramural NIH HHS Z01 ES101586NCI NIH HHS P30 CA013148NIAID NIH HHS R21 AI149267NIAMS NIH HHS R01 AR071189NIAMS NIH HHS R01 AR073004NIA NIH HHS R01 AG068395NIA NIH HHS R01 AG081228NIEHS NIH HHS R01 ES033682VA 1I01BX004293-01A1
6 · The paper itself

Abstract

Melatonin is widely present in Nature. It has pleiotropic activities, in part mediated by interactions with high-affinity G-protein-coupled melatonin type 1 and 2 (MT1 and MT2) receptors or under extreme conditions, e.g., ischemia/reperfusion. In pharmacological concentrations, it is given to counteract the massive damage caused by MT1- and MT2-independent mechanisms. The aryl hydrocarbon receptor (AhR) is a perfect candidate for mediating the latter effects because melatonin has structural similarity to its natural ligands, including tryptophan metabolites and indolic compounds. Using a cell-based Human AhR Reporter Assay System, we demonstrated that melatonin and its indolic and kynuric metabolites act as agonists on the AhR with EC

Indexed as

MelatoninReceptors, Aryl HydrocarbonBasic Helix-Loop-Helix ProteinsHumansKeratinocytesLigandsPPAR gammaAHR protein, humanBasic Helix-Loop-Helix ProteinsLigandsMelatoninPPAR gammaPPARG protein, humanReceptors, Aryl HydrocarbonAhRmelatoninmelatonin metabolitesmodelingPPARγreceptors

Identifiers

PMID37895177
PMCPMC10607054
OpenAlexW4387906889

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.